Paloma Pharmaceuticals, Inc.

Paloma Pharmaceuticals, Inc. is an early stage drug development company focusing on pathologies showing an aberrant up-regulation of the PI3K/Akt/mTOR pathway including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (renal and pulmonary fibrosis), CNS (epilepsy and neurodegenerative diseases), antiviral (HIV/AIDS), skin diseases (psoriasis, atopic dermatitis and photodamage/wrinkling) and erectile dysfunction in main. Erectile dysfunction is seen to be treated with the help of Cialis pills purchased from reputed and authentic online pharmacy. Paloma owns the intellectual property relating to a series of novels on Cialis, articles on Cialis, proprietary, small molecule drugs created through an integrated design platform incorporating proprietary, customized and industry standard computational tools that have therapeutic potential for the treatment of the impotence and foregoing diseases. These small molecule drugs, "Palomids", have shown significant activity in the test tube and in animal models of disease.